한국 치매 환자의 건강보험 의ㆍ한의 진료 비용에 관한 연구

• Published in: 동의신경정신과학회지 Vol. 30; no. 1; pp. 31 - 38
• Main Authors: 이정배, Jung Bae Lee, 강형원, Hyung Won Kang, 김재욱, Jaeuk Kim, 김가혜, Gahye Kim, 김남권, Nam-kwen Kim
• Format: Journal Article
• Language: Korean
• Published: 대한한방신경정신과학회 31.03.2019
• Subjects: Dementia; Early Dementia Diagnosis Technology; Mild cognitive impairment; 한의학
• ISSN: 1226-6396; 2234-4942
• DOI: 10.7231/jon.2019.30.1.031

Objectives: To identify the cost effectiveness of early dementia diagnosis using the 2014 Health Insurance Review & Assessment Service-National Patients Sample (HIRA-NPS). Methods: The medical costs of dementia between Western medical care and Korean medical care were compared through the reimbursement and non-reimbursement item code for dementia examination. In addition, the medical expenses of patients with dementia and mild cognitive impairment were compared and analyzed with respect to Western and Korean medical care. Results: There were 87,434 claims, of which 16,101 patients were diagnosed with dementia and 38,680,789,560 won was found to be the medical expenses. 12,881 patients (80.0%) with dementia, 3,144 patients (19.5%) with mild cognitive impairment, and 76 patients (0.5%) progressing from mild cognitive impairment to dementia. The proportion of medical expenses was 97.6% for dementia patients, 2.3% for mild cognitive impairment, and 1% for patients progressing from mild cognitive impairment to dementia. 86,070 claims (98.4%) were from Western medical care, with16,824 patients (98.2%), and the medical expenses was 38,546,895,400 won (99.7%). 1,361 claims (1.6%) were from Korean medical care, with 303 patients (1.8%), and the medical expenses was 133,894,160 won (0.3%). Conclusions: This study compared and analyzed the medical costs of dementia patients and the diagnosis of both Korean and Western medical care. The results of this study are expected to be used as basic research data for investigating cost effectiveness of developing early diagnosis of dementia.